Management of severe pulmonary hypertension in an infant with obstructed total anomalous pulmonary venous return using magnesium sulfate

International Journal of Cardiology

Volumn 56, Issue 2, 1996, Pages 131-135

  Lin, Shih Chiang ^a   Teng, Ru Jeng ^a   Wang, Jou Kou ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Magnesium sulfate; Pulmonary hypertension; Total anomalous pulmonary venous return

Indexed keywords

MAGNESIUM SULFATE; PROSTAGLANDIN E1;

ARTERIAL GAS; ARTICLE; CASE REPORT; HEART OUTPUT; HUMAN; HYPERVENTILATION; HYPOXEMIA; HYPOXIA; INFANT; INSPIRATORY CAPACITY; LUNG VEIN DRAINAGE ANOMALY; LUNG VOLUME; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SMOOTH MUSCLE CONTRACTION; VASODILATATION;

EID: 0030271933     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(96)02733-7     Document Type: Article

References (17)

1. [1] Park MK. Pediatric cardiology for practitioners, 2nd edn. Chicago: Year Book Medical Publishers, 1988; 106-122.
2. [2] Fyler DC. Total Anomalous Pulmonary Venous Return. In: Fyler DC, editor. Nadas' pediatric cardiology, 1st edn. Boston: Hanley and Belfus, 1992; 683-691.
3. [3] Bush A, Busst CM, Shinebourne EA. The use of oxygen and prostacyclin as pulmonary vasodilators in congenital heart disease. Int J Cardiol 1985; 9: 267-271.
4. [4] Hopkins RA, Bull C, Haworth SG, de Leval MR, Stark J. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 1991; 5: 628-634.
5. [5] Kermode J, Butt W, Shann F. Comparison between prostaglandin E1 and epoprostenol (prostacyclin) in infants after heart surgery. Br Heart J 1991; 66: 175-178.
6. [6] Journois D, Pouard P, Mauriat P, Malhre T, Vouh P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994; 107: 1129-1135.
7. [7] Thompson BT, Hales CA. Hypoxic pulmonary hypertension: acute and chronic. Heart Lung 1986; 15: 457-465.
8. [8] Cropp GIA. Reduction of hypoxic pulmonary vasoconstriction by magnesium chloride. J Appl Physiol 1968; 24: 755-760.
9. [9] Paidas CN, Dudgeon DL, Haller JA Jr, Clemens MG. Adenosin triphosphate: a potential therapy for hypoxic pulmonary hypertension. J Pediatr Surg 1988; 23: 1154-1160.
10. 4 in sheep. Pediatr Res 1990; 27: 351A.
11. [11] Abu-Osba YK, Galal O, Manasra K, Rejjal A. Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulfate. Arch Dis Child 1992; 67: 31-35.
12. [12] Wu TJ, Teng RJ, Yau Tsou KI. Persistent pulmonary hypertension of the newborn treated with magnesium sulfate in premature neonates. Pediatrics 1995; 96: 472-474.
13. [13] Ryan CA, Finer NN, Barrington KJ. Effects of magnesium sulfate and nitric oxide in pulmonary hypertension induced by hypoxia in newborn piglets. Arch Dis Child 1994; 71: 151-155.
14. [14] Mupanemunda RH, Edwards AD. Treatment of newborn infants with inhaled nitric oxide. Arch Dis Child 1995; 72: 131-134.
15. [15] Beghetti M, Habre W, Friedli B, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995; 73: 65-68.
16. [16] Gold ME, Buga GM, Wood KS, Byrns RE, Chaudhuri G, Ignarro LJ. Antagonistic modulatory roles of magnesium and calcium on release of endothelium derived relaxing factor and smooth muscle tone. Circ Res 1990; 66: 355-366.
17. [17] Okamoto K, Sato T, Kurose M, Kukita I, Fujii H, Taki K. Successful use of inhaled nitric oxide for treatment of severe hypoxemia in an infant with total anomalous pulmonary venous return. Anesthe 1994; 81: 256-259.